JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4576
Verrica Pharmaceuticals
VRCA
$75.2M
| $45K | ﹤0.01% |
415
-10
| -2% | -$1.32K |
2018 Q3
6 quarters
|
|
|
TPCO
4577
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $45K | ﹤0.01% |
5,652
-124
| -2% | -$1.37K |
2014 Q3
22 quarters
|
|
|
EMKR
4578
DELISTED
Emcore Corp
EMKR
| $45K | ﹤0.01% |
1,994
-321
| -14% | -$9.46K |
2017 Q3
10 quarters
|
|
4579
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$663M
| $44K | ﹤0.01% |
1,330
| – | – |
2015 Q4
17 quarters
|
|
4580
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.08B
| $44K | ﹤0.01% |
1,200
| – | – |
2015 Q4
17 quarters
|
|
|
KZR
4581
DELISTED
Kezar Life Sciences
KZR
| $44K | ﹤0.01% |
1,001
-6,816
| -87% | -$277K |
2018 Q3
6 quarters
|
|
|
NIU
4582
Niu Technologies
NIU
$147M
| $44K | ﹤0.01% |
6,255
-35,714
| -85% | -$301K |
2019 Q4
1 quarter
|
|
4583
Pro-Dex
PDEX
$205M
| $44K | ﹤0.01% |
+2,696
| New | +$47K |
2020 Q1
0 quarters
|
|
4584
ProShares Short Russell2000
RWM
$153M
| $44K | ﹤0.01% |
903
+743
| +464% | +$30.7K |
2019 Q1
4 quarters
|
|
4585
Global X Social Media ETF
SOCL
$88.7M
| $44K | ﹤0.01% |
+1,478
| New | +$50K |
2020 Q1
0 quarters
|
|
|
AKTS
4586
DELISTED
Akoustis Technologies Inc
AKTS
| $44K | ﹤0.01% |
8,129
-104
| -1% | -$730 |
2019 Q2
3 quarters
|
|
4587
Anavex Life Sciences
AVXL
$169M
| $43K | ﹤0.01% |
13,745
-329
| -2% | -$1.15K |
2019 Q2
3 quarters
|
|
4588
NLI Holdings
NL
$341M
| $43K | ﹤0.01% |
14,565
+3,613
| +33% | +$12K |
2016 Q4
13 quarters
|
|
4589
CALL
Tenet Healthcare
THC
$20.8B
| $43K | ﹤0.01% |
3,000
-762,000
| -100% | -$21.9M |
2019 Q1
4 quarters
|
|
|
NAGE
4590
Niagen Bioscience
NAGE
$221M
| $43K | ﹤0.01% |
13,134
+202
| +2% | +$776 |
2018 Q2
7 quarters
|
|
|
AIF
4591
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $43K | ﹤0.01% |
3,797
-7,349
| -66% | -$105K |
2015 Q4
17 quarters
|
|
4592
American Realty Investors
ARL
$259M
| $42K | ﹤0.01% |
4,541
+1,251
| +38% | +$16.2K |
2018 Q2
7 quarters
|
|
4593
PUT
Gogo Inc
GOGO
$286M
| $42K | ﹤0.01% |
+20,000
| New | +$85.5K |
2020 Q1
0 quarters
|
|
4594
iShares Morningstar Multi-Asset Income ETF
IYLD
$124M
| $42K | ﹤0.01% |
+2,092
| New | +$50.6K |
2020 Q1
0 quarters
|
|
4595
Transcontinental Realty Investors
TCI
$390M
| $42K | ﹤0.01% |
2,061
+481
| +30% | +$14.9K |
2017 Q4
9 quarters
|
|
|
IMV
4596
DELISTED
IMV Inc. Common Shares
IMV
| $42K | ﹤0.01% |
+2,411
| New | +$80.2K |
2020 Q1
0 quarters
|
|
|
JCP
4597
DELISTED
J.C. Penney Company, Inc.
JCP
| $42K | ﹤0.01% |
118,005
+10,719
| +10% | +$7.55K |
2013 Q2
27 quarters
|
|
4598
Replimune Group
REPL
$1.23B
| $41K | ﹤0.01% |
4,178
-53,787
| -93% | -$802K |
2018 Q3
6 quarters
|
|
4599
Rockwell Medical
RMTI
$34.9M
| $41K | ﹤0.01% |
180
-4
| -2% | -$1.14K |
2013 Q2
27 quarters
|
|
4600
TETRA Technologies
TTI
$888M
| $41K | ﹤0.01% |
132,559
+39,246
| +42% | +$46.5K |
2016 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.